Lee Baylis

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (Canada)

Hôpital Cochin

Analysis Group (United States)

National Jewish Health

Lee Baylis is an author at GlaxoSmithKline (United States) specializing in internal medicine, eosinophilic disorders, and treatment patterns epidemiology.

Publications per year

2022–2024

Publications

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype

Benjamin Terrier, David Jayne, Bernhard Hellmich et al. · ACR Open Rheumatology · 2023 · 31 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +16

Hypereosinophilic syndrome in Europe: Retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization

Jeremiah Hwee, Lynn Huynh, Shawn Du et al. · Annals of Allergy Asthma & Immunology · 2023 · 20 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +9

Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases

Mary Jo Strobel, Debbie Alves, Florence Roufosse et al. · Journal of Patient Experience · 2022 · 14 citations · Full text

Nursing, Internal Medicine, Communication In Serious Illness +15

Burden of eosinophilic granulomatosis with polyangiitis in Europe

Rupert W. Jakes, Namhee Kwon, Lynn Huynh et al. · ERJ Open Research · 2024 · 14 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

1–4 of 4